List of redirects
Jump to navigation
Jump to search
Showing below up to 50 results in range #871 to #920.
- ANTHEM–TIMI-32 → Anticoagulation With Rnapc2 To Eliminate Mace/Timi 32
- ANTIBIO → Antibiotic Therapy After An Acute Myocardial Infarction
- ANTIPSYCHOTIC DRUG → Antipsychotics
- ANTIPSYCHOTIC DRUGS → Atypical antipsychotics
- ANUG → Trench mouth
- ANZ-Carvedilol → Australia-New Zealand Heart Failure Research Collaborative Group Carvedilol Trial
- AO → Aorta
- AOM → Otitis media
- AOS → Loeys-Dietz syndrome
- AOSD → Adult-onset Still's disease
- AP → Alkaline phosphatase
- AP-1 site → AP-1 Binding Site
- APAF → Ablation For Paroxysmal Atrial Fibrillation (Apaf) Trial
- APAP → Paracetamol detailed information
- APASS → Antiphospholipid Antibody Stroke Study
- APB → Premature atrial contraction
- APCEDS → Autoimmune polyendocrine syndrome
- APC Resistance, Leiden Type → Factor V Leiden
- APC gene → APC (gene)
- APC resistance → Activated protein C resistance
- APC resistance, Leiden type → Factor V Leiden
- APD → Avoidant personality disorder
- APECED → Autoimmune polyendocrine syndrome
- APECED syndrome → Autoimmune polyendocrine syndrome
- APEX AMI → Assessment Of Pexelizumab In Acute Myocardial Infarction
- APH → Antepartum haemorrhage
- API Healthcare Coloufree Childrens Paracetamol → Paracetamol detailed information
- API Healthcare Colourfree Childrens Paracetamol Double Strength → Paracetamol detailed information
- API Healthcare Paracetamol → Paracetamol detailed information
- APL → Acute promyelocytic leukemia
- APLAUSE → Anti-Platelet Treatment After Intravascular Ultrasound Guided Optimal Stent Expansion
- APL differentiation syndrome → Retinoic acid syndrome
- APML → Acute promyelocytic leukemia
- APML differentiation syndrome → Retinoic acid syndrome
- APO-Atenol → Atenolol
- APO-Go → Apomorphine
- APO-Go Pen → Apomorphine
- APOCARD → Imaging In Cardiac Transplant Patients
- APPI → Amyloid precursor protein
- APPRAISE-1 → Safety Of The Factor Xa Inhibitor, Apixaban, In Combination With Antiplatelet Therapy After Acute Coronary Syndromes: A Dose-Guiding Trial
- APPROACH → Assessment On The Prevention Of Progression By Rosiglitazone On Atherosclerosis In Diabetes Patients With Cardiovascular History
- APRES → Angiotensin-Converting Enzyme Inhibition Post Revascularization Study
- APRICOT → Antithrombotics In The Prevention Of Reocclusion In Coronary Thrombolysis
- APRICOT-2 → Antithrombotics In The Prevention Of Reocclusion In Coronary Thrombolysis-2
- APS1 → Autoimmune polyendocrine syndrome
- APS 1 → Autoimmune polyendocrine syndrome
- APS type 1 → Autoimmune polyendocrine syndrome
- APS type 2 → Autoimmune polyendocrine syndrome
- APS type 3 → Autoimmune polyendocrine syndrome
- APT → Amiodarone pulmonary toxicity